← SynDRA
FORMESTANE
SynDRA canonical compound SYN0004602 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | CYP19A1 |
| Mechanism of action | aromatase inhibitor |
| Indication | breast cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PGR
- NR1I2
- ESR1
- ADORA1
- MC3R
- OPRD1
- NR3C1
- NPY1R
- MLNR
- MAOA
- PDE3A
- KCNH2
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- OPRM1
- PDE4D
- HSD17B7
- PTGS2
- SAMHD1
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1B1
- SLCO1B3
- SMN1
- TARDBP
- TBXA2R
- TDP1
- THRB
- HTR1A
- HRH3
- ADORA2A
- CCKAR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- CP19A
- CP2CJ
- CP2D6
- CP3A4
- CP3A7
- ESRRA
- GLI3
- PRGR
- TSHR
Drug classes
- Antineoplastic Agents
- Aromatase Inhibitors
- Enzyme Inhibitors
- Estrogen Antagonists
- Hormone Antagonists
- Steroid Synthesis Inhibitors
ATC classes
- L02B · HORMONE ANTAGONISTS AND RELATED AGENTS
Cross-references
Synonyms
- lentaron
- Formestano
- 4-oh-androstene-3,17-dione
- CGP-32349
- NSC-282175
- Lentaron
- 4-Hydroxyandrost-4-ene-3,17-dione
- 4-Hydroxyandrostenedione
- CGP 32349
- Lentaron(R)
- 4-OH-A
- B, Aromatase inhibitor
- 4-Hydroxy-4-androstene-3,17-dione
- NSC 282175
- 17-dione
- 4-OHA
- Formestane [INN:BAN]
- UNII-PUB9T8T355
- CCRIS 7483
- ANDROST-4-ENE-3,17-DIONE, 4-HYDROXY-
- 4-Hydroxy-delta(sub 4)-androstenedione
- BRN 1889793
- MLS002153359
- MLS000028826
- PUB9T8T355
- CHEBI:75172
- 4-OHAD
- (8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
- 4-hydroxy-Delta(4)-androstenedione
- Formestane (INN)
- SMR000058722
- FORMESTANE [INN]
- (8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione
- CAS-566-48-3
- formestano
- formestanum
- SaveCream
Look up FORMESTANE in the interactive SynDRA portal →